204 results on '"Rymo L"'
Search Results
2. Epstein-Barr Virus-Encoded Nuclear Antigen 2 Activates the Viral Latent Membrane Protein Promoter by Modulating the Activity of a Negative Regulatory Element
3. In Vitro Synthesis of Rous Sarcoma Virus-Specific RNA is Catalyzed by a DNA-Dependent RNA Polymerase
4. Sp1 binds to the G allele of the−1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production
5. The Sp1 transcription factor binds to the G-allele of the –1087 IL-10 gene polymorphism and enhances transcriptional activation
6. No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
7. Sp1 binds to the G allele of the −1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production
8. Apolipoprotein E polymorphism in patients with cataract
9. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion
10. The 5’Flanking Region of the Gene for EBNA2 Contains a Cell Type Specific cis-Acting Regulatory Element that Activates Transcription in Transfected B-Cells
11. Angiotensin-Converting Enzyme Gene I/D Polymorphism in Malignant Hypertension
12. The Sp1 transcription factor binds to the G-allele of the –1087 IL-10 gene polymorphism and enhances transcriptional activation
13. Functional interaction of Oct transcription factors with the family of repeats in Epstein–Barr virus oriP
14. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
15. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
16. B cell-specific activation of the Epstein--Barr virus-encoded C promoter compared with the wide-range activation of the W promoter
17. Domains of the Epstein--Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters
18. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein--Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter
19. Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24→qter by fluorescence in situ hybridization
20. Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
21. Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B
22. Different fibrinolytic potential in cultured human adult and umbilical vein endothelial cells
23. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines
24. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
25. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
26. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates
27. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region
28. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein
29. Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization
30. Relationship between clinical stage, histopathology and antibody titers against the second epstein-barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
31. The 5′ flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
32. Proteomic Analysis Using Protein Chips to Detect Biomarkers in Cervical and Amniotic Fluid in Women with Intra-Amniotic Inflammation
33. Quantitative analysis of specific mRNA species in minute cell samples by RT-PCR and flow cytometry
34. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease.
35. Transfer of the Epstein‐Barr virus genes coding for small RNAs to human lymphoid cells with a vector carrying a dominant selectable marker.
36. Cytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein‐Barr virus and human adenoviruses.
37. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.
38. BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.
39. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells
40. Sites of sequence variability in Epstein-Barr virus DNA from different sources.
41. Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells
42. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.
43. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.
44. In VitroSynthesis of Rous Sarcoma Virus-Specific RNA is Catalyzed by a DNA-Dependent RNA Polymerase
45. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus.
46. Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24→qter by fluorescence in situ hybridization.
47. Polyclonal origin of T lymphocytes in human atherosclerotic plaques
48. Clinical mass spectrometry in neuroscience. Proteomics and peptidomics
49. Studies on the Structure and Synthesis of Rous Sarcoma Virus RNA
50. Identification of Sequences in Epstein-Barr Virus DNA Required for the Expression of the Second Epstein-Barr Virus-determined Nuclear Antigen in COS-1 Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.